SS4. Secondary Vascular Interventions After EVAR  by Quinney, Brenton E. et al.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 11S Abstracts 5SG. M. LaMuraglia: Nothing to disclose; V. I. Patel:
Nothing to disclose.
SS3.
In Situ Rifampin-Soaked Grafts Are Durable With
Low Reinfection Rates in Patients With Aortic Graft
Enteric Erosion or Fistula
Gustavo S. Oderich, Thomas C. Bower, Jan Hofer, Manju
Kalra, Audra A. Duncan, Joseph J. Ricotta, Peter Gloviczki.
Division of Vascular and Endovascular Surgery, Mayo
Clinic, Rochester, MN
Objectives: We previously reported that in situ rifampin-
soaked grafts (ISR) were safe in selected patients with aortic
graft infections, with the best results in those with aortic
graft enteric erosion or fistula (AGEF). This study evaluates
the late results of ISR for AGEF.
Methods: From 1990 to 2008 183 patients were
treated for aortic graft infections (121 primary and 62
AGEF). We reviewed 54 patients treated for AGEF with a
standard protocol, which included excision of the infected
graft, intestinal repair, ISR with omental wrap, and long-
term antibiotics. We excluded 8 AGEF patients (13%)
treated with axillofemoral grafts (AXFG, n 5) or femoral
vein grafts (n  3) due to excessive perigraft purulence.
End-points were early morbidity and mortality, and late
survival, reinfection and graft-related complication rates.
Results:There were 45male and 9 female patients with
mean age of 69 9 years. Presentation was gastrointestinal
bleeding in 30 patients, fever in 25, and hemorrhagic shock
in 8. Other features were perigraft fluid/purulence in 42
patients and abscess in 5 (drained in 3). Excision of the
entire graft was required in 38 patients, and 16 had partial
excision to incorporated graft. Total operating time was
6  4 hours. Postoperative complications occurred in 28
patients (52%), and there were 5 deaths (9%), 3 in patients
with shock. The hospital stay was 24  21 days. Five-year
patient survival, primary graft patency, and limb salvage
rates were 66 7%, 88 4% and 100%. There were no late
graft-related deaths. After a median follow-up of 38
months, there was 1 (2%) graft reinfection treated with
AXFG, 3 noninfected femoral aneurysms, and 5 graft limb
thrombosis/restenosis requiring revision.
Conclusions: In situ rifampin-soaked grafts with omen-
tal wrap and long-term antibiotics are associated with low
reinfection rates (2%) in properly selected patients with AGEF
who do not have excessive perigraft purulence. Graft patency
and limb salvage rates are excellent.
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Video Presentation
Para-visceral Aortic Endarterectomy: Treatment of
Choice for Coral-reef Aortic Plaque
Brian G. DeRubertis, Peter L. Lawrence, William Qui-
nones-Baldrich, Ankur Chandra. Department of Surgery,
UCLA School of Medicine, Los Angeles, CA
Background: While endovascular intervention has sig-
nificantly impacted the treatment of aortic, mesenteric, and
renal arterial occlusive disease, certain disease patterns re-
main best suited for open surgical reconstruction. Eccentric
plaque limited to the para-mesenteric and para-renal aorta
can be effectively treated by retroperitoneal trans-aortic
endarterectomy with excellent results.
Technical Description: A 67-year-old woman pre-
sented with recent onset of bilateral lower extremity
claudication, poorly controlled hypertension, renal in-
sufficiency and several episodes of flash pulmonary
edema. The video presentation includes discussion of the
patient’s clinical presentation and results of her preoper-
ative workup, including magnetic resonance arteriogra-
phy demonstrating occlusive, eccentric and heavily-cal-
cified paramesenteric and pararenal aortic plaque. The
video emphasizes the operative technique for retroperi-
toneal aortic exposure, trap-door aortotomy, and aortic
endarterectomy with complete aortic plaque removal
and reconstruction.
Author Disclosures: A. Chandra: Nothing to disclose;
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SS4.
Secondary Vascular Interventions After EVAR
Brenton E. Quinney, Shardul B. Nagre, Steve M. Taylor,
Marc A. Passman, Mark A. Patterson, Bart R. Combs,
Bruce G. Lowman, William D. Jordan. Vascular Surgery,
University of Alabama at Birmingham, Birmingham, AL
Objectives: Secondary interventions required after pri-
mary endovascular repair of abdominal aortic aneurysms
(EVAR) may affect the short-term benefit of EVAR. This
review details a single-institution 10-year experience with
EVAR to evaluate the impact of secondary interventions on
the clinical utility of EVAR.
Methods: All patients undergoing EVAR were identi-
fied from a prospectively maintained registry. Medical
records were reviewed for outcomes, complications and
secondary vascular interventions.
Results: Between October 1999 and May 2009, 1065
EVAR procedures were performed among 994 patients at
our institution. Within a specifically designed surveillance
protocol which includes computed tomography (CT) scan-
ning and ultrasound, there were 3110 imaging encounters
recorded in 920 patients. Endoleak was identified in 243
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including, Type I (n  56, 23.0%), Type II (n  166,
68.3%), Type III (n  11, 4.5%), Type IV (n  2, 0.8%),
and Type V (n 8, 3.3%). One hundred and seven second-
ary interventions were performed in 85 patients (9.2%) for
EVAR related problems, and included placement of an iliac
extender (n  36, 33.7.%), proximal cuff placement (n 
20, 18.7%), embolization of a branch vessel (n  24,
22.4%), stent graft relining (n  15, 14.0%), ligation of a
branch vessel (n  4, 3.7%) fem-fem bypass grafts (n  3,
2.8%), ilio-femoral thrombectomy (n  3, 2.8%), and
hypogastric artery stent placement (n  2, 1.9%). Sixteen
endografts (1.7%) required explantation after primary fail-
ure (10) or failed secondary intervention (6). Indications
for explant included expanding size or persistent endoleak
(n  12), infection (n  2), and rupture (2). Three
instances of rupture following EVAR were noted.
Conclusions: Secondary aneurysm related procedures
after EVAR were required in10% of this population with
most requiring minimally invasive catheter based proce-
dures. Long-term surveillance remains important to pro-
vide optimal vascular outcomes for these patients.
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A Comparison of Indirect Radiation Dose Estimates
With Directly Measured Radiation Dose for Patients
and Operators During Complex Endovascular
Procedures
Giuseppe Panuccio, Roy K. Greenberg, Kevin Wunderle,
Tara Mastracci, Matthew J. Eagleton, William Davros.
Vascular Surgery, Cleveland Clinic Foundation, Cleveland,
OH
Objectives:To assess the accuracy of indirect estimated
radiation doses during endovascular thoracoabdominal an-
eurysm repair (eTAAA).
Methods: Patients undergoing eTAAA had imaging
system generated indirect radiation parameters recorded
concurrently with direct measurements of radiation expo-
sure patterns using radiochromatic film. Operator dose was
determined by electronic dosimeters. Observed radiation
exposure patterns were reproduced in phantoms allowing
for effective radiation dose calculations. Continuous vari-
ables were assessed with scatter plots and Pearson coeffi-
cients.
Results: No patients had evidence of radiation induced
skin injury. Cumulative air kerma (CAK) exceeded 15Gy in
3 patients, however, direct measurements were below
15Gy in all patients. Peak skin dose (PSD), quantified using
gafchromic film, correlated weakly with fluoroscopy time(FT) but better with CAK and kerma air product (KAP).
The formula“PSD 0.6770.257CAK”provides the best
estimate of actual PSD. The average effective dose was
119.68mSv (for type II or III eTAAA) and 76.46mSv (type
IV eTAAA). Mean operator effective dose was 0.17mSv/
case, and correlated best with KAP (r 0.82, p 0.0001).
Conclusions: FT, CAK and KAP represent poor mark-
ers of PSD, and directly measured PSD did not correlate
with clinical events. The effective radiation dose of eTAAA
is equivalent to 2 preoperative CT scans. An operator could
perform up to 294 eTAAA annually before reaching the
maximum recommended operator dose.
Indirect calculations and direct measurements of dose
Parameters
Total
Group
(n  47)
Type II
and III
(n  18)
Type IV
(n  29)
Correlation with
measured PSD
Indirect FT (min) 104.42 140.67 81.92 r 0.55 p 0.0001
Indirect CAK (Gy) 7.45 9.64 6.09 0.80 0.0001
Indirect KAP (Gy cm2) 781.62 1005.73 642.51 0.76 0.0001
Direct Measured PSD
(Gy)
2.59 3.16 2.24
Direct 95% Isodose area
(cm2)
4.03 4.86 3.51
Direct Patient effective
dose (mSv)
Direct Procedure 87.3 112.3 71.8
Direct Diagnostic CT 34.59 34.31 34.76
Direct Operator
effective dose
(mSv)
0.17 0.23 0.13
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Venous Specific Eph-B4 Regulates Vein Graft Thick-
ening via Caveolin-1
Akihito Muto, Tai Yi, Kenneth Harrison, Alberto Davalos,
William C. Sessa, Alan Dardik. Yale University School of
Medicine, New Haven, CT
Objectives: Successful vein graft adaptation to the
arterial environment is critical to maintain long-term vas-
cular graft patency. However, the mechanism of vein graft
adaptation remains unclear. Since Eph-B4, an embryonic
determinant of venous identity, expression is reduced dur-
ing vein graft adaptation, we determined whether Eph-B4,
and the shear stress-sensing caveolin-1 (cav-1), play mech-
anistic roles to limit wall thickening during vein graft
adaptation.
Methods: Full length mouse Eph-B4 cDNA was in-
serted into the pShuttle-IRES-hrGFP2 vector and the
cav-1 binding domain (CBD) was mutated at w804. In-
trathoracic inferior vena cava was harvested from wild-type
(WT) or cav-1 knockout (cav-1-KO) mice and placed as an
